A patient is undergoing treatment for a ventricular arrhythmia with amiodarone.
The patient has been given a 150 mg bolus of amiodarone IV and is currently on a continuous infusion of 1 mg/min.
The nurse observes a heart rate of 60 beats per minute and a blood pressure of 88/54 mm Hg. What action should the nurse take next, in addition to notifying the provider?
Increase the amiodarone infusion rate to 1.5 mg/min.
Decrease the amiodarone infusion rate to 0.5 mg/min.
Continue the amiodarone infusion at 1 mg/min.
Discontinue the amiodarone infusion.
The Correct Answer is B
Choice A rationale:
Increasing the amiodarone infusion rate would worsen the patient's bradycardia and hypotension. Amiodarone is a class III antiarrhythmic drug that works by prolonging the action potential duration in cardiac cells. This can lead to a decrease in heart rate and contractility.
Increasing the dose in this patient could lead to further hemodynamic compromise.
Choice B rationale:
Decreasing the amiodarone infusion rate is the most appropriate action in this situation. This will help to mitigate the drug's effects on the patient's heart rate and blood pressure.
A dose reduction may allow the heart rate to recover to a safer level while still maintaining the antiarrhythmic benefits of amiodarone.
Choice C rationale:
Continuing the amiodarone infusion at the current rate is not appropriate, as it is likely to worsen the patient's bradycardia and hypotension.
Maintaining the current dose could lead to further clinical deterioration.
Choice D rationale:
Discontinuing the amiodarone infusion entirely may not be necessary at this point. The patient's arrhythmia may still require treatment with amiodarone.
A dose reduction may be sufficient to address the patient's hemodynamic instability while still providing therapeutic benefits.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["A","B","D"]
Explanation
Choice A rationale:
Seizure precautions are necessary because:
The patient has ingested multiple drugs, some of which can lower the seizure threshold, such as benzodiazepines. Naloxone, while reversing opioid overdose, can also precipitate seizures in some individuals.
Flumazenil, used to reverse benzodiazepine overdose, can also induce seizures, especially in patients with a history of epilepsy or benzodiazepine dependence.
The potential for drug interactions and unpredictable effects of multiple drug ingestion further increases the risk of seizures. Specific seizure precautions include:
Placing the patient in a bed with padded side rails. Having oxygen and suction equipment readily available.
Keeping intravenous access open for potential administration of anticonvulsant medications. Closely monitoring the patient's neurological status for any signs of seizure activity.
Choice B rationale:
Aspiration precautions are crucial due to:
The patient's unconscious state, which impairs their ability to protect their airway.
The possibility of vomiting, which can occur as a side effect of naloxone or flumazenil administration.
The potential for aspiration of gastric contents, which can lead to serious respiratory complications, such as pneumonia. Specific aspiration precautions include:
Positioning the patient on their side in the recovery position. Continuously monitoring the patient's respiratory status.
Having suction equipment ready to clear the airway if necessary.
Considering intubation and mechanical ventilation if the patient's airway is compromised.
Choice D rationale:
Fall precautions are essential because:
The patient is unconscious and may be disoriented or uncoordinated upon regaining consciousness.
The effects of the ingested drugs, as well as the medications administered, can impair balance and coordination. Falls can result in serious injuries, such as head trauma or fractures.
Specific fall precautions include:
Keeping the bed in a low position with side rails up.
Assisting the patient with ambulation when they are able to move. Ensuring the patient's environment is free of tripping hazards.
Providing close supervision and assistance as needed.
Choice C rationale:
Suicide precautions are not routinely implemented in this scenario because:
The patient's primary presentation is drug overdose, not active suicidal ideation or attempts.
The focus of care is on addressing the immediate medical complications of the overdose and stabilization.
However, a thorough suicide risk assessment should be conducted once the patient is medically stable to determine if ongoing suicide precautions are necessary.
Correct Answer is D
Explanation
Choice A rationale:
Amiodarone is an antiarrhythmic medication that is often used to treat ventricular tachycardia and ventricular fibrillation. However, it is not the first-line drug for Torsades de Pointes. In fact, amiodarone can actually worsen QT prolongation and increase the risk of Torsades de Pointes.
It's important to note that amiodarone has a long half-life and can accumulate in the body over time, further increasing the risk of QT prolongation.
Additionally, amiodarone can have several serious side effects, including pulmonary toxicity, thyroid dysfunction, and liver damage.
Choice B rationale:
Lidocaine is another antiarrhythmic medication that is sometimes used to treat ventricular arrhythmias. However, it is also not the first-line drug for Torsades de Pointes.
Lidocaine is less likely to worsen QT prolongation than amiodarone, but it can still have this effect in some patients.
Additionally, lidocaine has a short half-life and must be given as a continuous infusion, which can be challenging in a critical care setting.
Choice C rationale:
Atropine is a medication that is used to increase heart rate. It is not effective in treating Torsades de Pointes and is not indicated in this situation.
Atropine works by blocking the vagus nerve, which slows heart rate. In Torsades de Pointes, the heart rate is already very fast, so atropine would not be helpful.
Additionally, atropine can have several side effects, including dry mouth, blurred vision, and urinary retention.
Choice D rationale:
Magnesium sulfate is the first-line drug for treating Torsades de Pointes. It works by stabilizing the electrical activity of the heart and preventing further episodes of arrhythmia.
Magnesium sulfate is a relatively safe medication with few side effects. It can be given as an intravenous infusion or as an intramuscular injection.
Studies have shown that magnesium sulfate is effective in terminating Torsades de Pointes and preventing recurrences.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.